SG158841A1 - Genes - Google Patents

Genes

Info

Publication number
SG158841A1
SG158841A1 SG200908691-9A SG2009086919A SG158841A1 SG 158841 A1 SG158841 A1 SG 158841A1 SG 2009086919 A SG2009086919 A SG 2009086919A SG 158841 A1 SG158841 A1 SG 158841A1
Authority
SG
Singapore
Prior art keywords
seq
sequence shown
sequence
genes
pdcd6
Prior art date
Application number
SG200908691-9A
Other languages
English (en)
Inventor
Chee Furng Wong
Miranda Gek Sim Yap
Original Assignee
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agency Science Tech & Res filed Critical Agency Science Tech & Res
Publication of SG158841A1 publication Critical patent/SG158841A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
SG200908691-9A 2004-12-30 2005-12-28 Genes SG158841A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64033304P 2004-12-30 2004-12-30

Publications (1)

Publication Number Publication Date
SG158841A1 true SG158841A1 (en) 2010-02-26

Family

ID=36615341

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200908691-9A SG158841A1 (en) 2004-12-30 2005-12-28 Genes

Country Status (9)

Country Link
US (5) US7846894B2 (ko)
EP (6) EP1997890A1 (ko)
JP (1) JP5089400B2 (ko)
KR (1) KR20070082597A (ko)
CN (3) CN101133156A (ko)
AU (1) AU2005322686B2 (ko)
IL (1) IL183361A0 (ko)
SG (1) SG158841A1 (ko)
WO (1) WO2006071200A2 (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9228006B2 (en) 2012-03-16 2016-01-05 University Health Network Methods and compositions for modulating Toso activity
EP2674495A1 (en) * 2012-06-14 2013-12-18 Sanofi CHO expression system
EP2914730A1 (en) * 2012-11-05 2015-09-09 Celonic AG Expression system
CN105683218A (zh) 2013-07-03 2016-06-15 大学保健网络 针对toso的抗体
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
CN107630038A (zh) * 2017-09-15 2018-01-26 浙江大学 提高老年大鼠骨髓间充质干细胞移植后生存能力的方法
WO2019180607A1 (en) * 2018-03-19 2019-09-26 Centre For Cellular And Molecular Platforms A vector, a host cell and a method thereof
CN108359632A (zh) * 2018-03-30 2018-08-03 吉林冠界生物技术有限公司 Mdck细胞系、复制病毒的方法及其应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
JPH02500329A (ja) 1987-05-21 1990-02-08 クリエイテイブ・バイオマリキユールズ・インコーポレーテツド ターゲット化多機能蛋白質
JP3771253B2 (ja) 1988-09-02 2006-04-26 ダイアックス コープ． 新規な結合タンパク質の生成と選択
AU634186B2 (en) 1988-11-11 1993-02-18 Medical Research Council Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
US6747138B1 (en) 1995-04-03 2004-06-08 Regents Of The University Of Michigan Methods and compositions for regulating Fas-associated apoptosis
EP0816497A3 (en) * 1996-06-26 1999-12-22 Smithkline Beecham Corporation Human requiem polypeptide for apoptosis
US6544523B1 (en) 1996-11-13 2003-04-08 Chiron Corporation Mutant forms of Fas ligand and uses thereof
GB9625283D0 (en) * 1996-12-04 1997-01-22 Janssen Pharmaceutica Nv Vertebrate homologues of unc-53 protein of c.elegans or functional eqivalents thereof and cdna sequences coding for said homologue
US20040143111A1 (en) * 1997-04-17 2004-07-22 Incyte Corporation Novel apoptosis-associated protein
US6451759B1 (en) 1998-01-14 2002-09-17 The Regents Of The University Of California Noncleavable Fas ligand
US6683168B1 (en) 1998-04-21 2004-01-27 Boston Medical Center Corporation Genes and methods that modulate apoptosis
AU3753099A (en) * 1998-04-21 1999-11-08 Trustees Of Boston University Novel genes and methods that modulate apoptosis
US6015712A (en) * 1999-07-19 2000-01-18 Isis Pharmaceuticals Inc. Antisense modulation of FADD expression
EP1220934B1 (en) * 1999-09-27 2005-12-21 Genentech, Inc. Methods for making recombinant proteins using apoptosis inhibitors
US7575860B2 (en) * 2000-03-07 2009-08-18 Evans David H DNA joining method
US20040023385A1 (en) * 2002-08-05 2004-02-05 Isis Pharmaceuticals Inc. Antisense modulation of requiem expression
US7326768B2 (en) * 2003-02-05 2008-02-05 Juan Saus Goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders
CN1548054A (zh) * 2003-05-08 2004-11-24 陆爱丽 预防或治疗sars冠状病毒的药物

Also Published As

Publication number Publication date
CN101875692A (zh) 2010-11-03
US20110318831A1 (en) 2011-12-29
EP2298887A1 (en) 2011-03-23
AU2005322686A1 (en) 2006-07-06
WO2006071200A2 (en) 2006-07-06
IL183361A0 (en) 2007-09-20
CN101875957A (zh) 2010-11-03
KR20070082597A (ko) 2007-08-21
EP1831366A2 (en) 2007-09-12
CN101133156A (zh) 2008-02-27
EP2298890A1 (en) 2011-03-23
WO2006071200A3 (en) 2007-01-25
JP5089400B2 (ja) 2012-12-05
EP2298888A1 (en) 2011-03-23
AU2005322686B2 (en) 2012-01-19
US20110318316A1 (en) 2011-12-29
US20110318317A1 (en) 2011-12-29
EP2298889A1 (en) 2011-03-23
US7846894B2 (en) 2010-12-07
JP2008526200A (ja) 2008-07-24
EP1997890A1 (en) 2008-12-03
US20080295190A1 (en) 2008-11-27
US20110129927A1 (en) 2011-06-02

Similar Documents

Publication Publication Date Title
SG158841A1 (en) Genes
HK1054619A1 (en) Fuel cartridge and reaction chamber.
HK1156862A1 (en) Compstatin analogs with improved activity
PT2332968T (pt) Péptidos alfa-helicoidais adequados para a activação ou inibição da morte celular
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
WO2005007818A3 (en) Exo-specific amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof
WO2004080148A3 (en) Novel nucleic acids and polypeptides
AU2003248119A1 (en) Novel peptide synthase gene
EP1733039A4 (en) IMPROVED BACTERIA CELL FOR DIRECT EXPRESSION OF PEPTIDES
TW200722436A (en) A peptide-immunoglobulin-conjugate
AU2003261437A8 (en) Fuel cell voltage feedback control system
IL158159A0 (en) NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha-21 GENE
WO2003074546A8 (de) Streptavidin-bindungspeptid
WO2006127822A3 (en) Scytovirin domain 1 related polypeptides
SG10201803541TA (en) Biologically active c-terminal arginine-containing peptides
WO2005049806A3 (en) Novel nucleic acids and polypeptides
WO2003093305A3 (en) Teneurin c-terminal associated peptides (tcap) and uses thereof
MX2009009370A (es) Conjugados del complemento de peptido.
SG146640A1 (en) Isolated photoprotein mtclytin, and use thereof
WO2003091383A3 (fr) Epitopes t de l'antigene epha2.
AU2003238955A1 (en) Aquariums switching current water director (scwd)
WO2005077975A3 (en) Polypeptides comprising the pleckstrin homology domain of ect2 and their binding specificities to phosphatidylinositols
EP2129359A4 (en) GPCR1 35 OR GPCR1 ANTAGONIST CHIMERIC PEPTIDE 42
HK1082510A1 (en) Promoter to il-18bp, its preparation and use
GB0125773D0 (en) Constructs